Global Drug Delivery Systems Market Trends, Applications, Analysis, Growth, and Forecast: 2018 to 2027
MarketResearch.biz delivers in-depth insights on the drug delivery system market in its upcoming report titled, “Drug Delivery System Market Trends, Applications, Analysis, Growth, and Forecast: 2018 to 2027”. The drug delivery system market is estimated to register a CAGR of XXX% in terms of value during forecast period 2018–2027. The report offers in-depth insights, revenue details, and other vital information regarding the target market, and the various trends, drivers, restraints, opportunities, and threats till 2027. The report offers insightful and detailed information regarding the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The drug delivery system market report has been segmented on the basis of route of administration, end user and region.
Drug delivery system is a process of administering a pharmaceutical substance to achieve therapeutic effect in humans or animals. Drug delivery system specifically focuses on the target therapy i.e.; the drugs release their active ingredients only at target site of the body within a period of time. An ideal drug delivery system needs to perform multiple functions such as reduce/eliminate adverse effects due to the drug, improve solubility, improve stability of the drug, should be non-toxic to the biological system etc. Drug delivery systems plays an important role in the administration of drugs, vaccines, and diagnostic agents. Natural polymers also have an important role in drug delivery. The development of upcoming drug delivery technologies can be applied for solving problems regarding pharmaceutical, biopharmaceutical and pharmacokinetic aspects thus, the delivery systems are growing worldwide.
Rising prevalence of diseases such as cardiovascular diseases, diabetes, and cancer etc. is the major driver, driving the growth of drug development system market across the globe. In addition, continuous advancement in delivery system, ageing of the world’s population, government initiatives for R&D of drug delivery system are the factors boosting the growth of drug delivery market. However, the stringent rules of drug regulatory authorities for drug delivery system may hinder the growth of drug delivery system market.
Pharmaceutical companies are looking to extend their patents lifetimes by collaborating with drug delivery technology companies. Most of the drug delivery products therefore had reach the market as a result collabration between drug delivery companies and pharmaceutical companies. This joint venture is advantages for R&D, to bring new drug into the market as drug delivery systems. The government of various developed country like US are initiative for bringing new drug delivery system. American consumers are having access to the safest and most advanced pharmaceutical system in the world due to FDA’s Center for Drug Evaluation and Research (CDER). Various players are working hand-in-hand for innovation in various drug delivery system such as inhalation, transdermal, oral and topical etc. as well as for ensuring the highest standards of manufactured product delivery in drug delivery systems.
The market in North America currently dominates the global drug delivery system market owing to increase in research & development expenses for advanced drug delivery devices in this region. Asia Pacific drug delivery system market is expected to be an emerging market for drug delivery system due major players are entering into joint venture for R&D activities owing to lowered labour cost in this region.
Segmentation on the basis of route of administration’s:
Segmentation on the basis of end user:
- Research Centers
- Ambulatory Surgical Centers
- Pharmaceutical and Biotechnology Companies
- Other end Users (Diagnostic Centers, Home Care settings etc.)
Segmentation on the basis of region:
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Particular Scope Region
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East and Africa
- South Africa
- Rest of Middle East and Africa
Actual Year 2017 Estimated Year 2018 Forecast Period 2018–2027 Revenue in US$
- Hoffmann-La Roche Ltd.
- Bayer AG
- Novartis AG
- Johnson & Johnson, Inc.
- GlaxoSmithKline plc,
- Becton, Dickinson & Company
- Merck & Co., Inc.
- Pfizer, Inc.
- AstraZeneca plc.,
- Antares Pharma, Inc.
Request for TOC
Request for Customization
Don't just take our word. We are trusted by these great companies!